One of the phenotypes observed in A20/Atg16l1 dKO mice is a reduction in goblet and Paneth cells (particularly the latter), a phenomenon typically seen in IBD patients and in many experimental IBD mouse models48. Here, ATG16L1 is linked to inflammatory bowel disease.